Life Sciences Update: February 2024

 

Trends in Life Sciences 
Expect both biotech and pharma research and development to continue to decode treatments and drugs for existing conditions, and in many cases, work together to achieve results.  There is reason for optimism among startups, as significant dry powder exists. However, the lessons learned in 2023 still apply in 2024. Strong clinical trials, along with financial discipline, are key components to attract funding. 
>>Access Trends in Life Sciences  External Link

Leasing Market Fundamentals 
Inventory growth has been a direct response to employment-fueled growth as markets raced to meet demand. A recalibration is currently underway while market fundamentals rebalance. 
>>Access Leasing Market Fundamentals  External Link

Labor 
Life sciences labor market experienced some easing in 2023. Occupations that are high in demand remain difficult to fill. 
>>Access Labor External Link

Global Funding 
Global venture capital volume has fallen from pandemic-fueled highs, but 2024 could be the year that the dry powder sitting on the sidelines begins to be deployed in earnest. 
>>Access Global Funding  External Link

Clinical Trials Key Growth Driver 
Drug trials continue to dominate the global clinical trials market.  FDA approvals soared to a five-year high in 2023, helping to fuel demand for life sciences space and igniting investor enthusiasm. 
>>Access Clinical Trials Key Growth Driver External Link

Emerging Markets 
Discover trends in emerging markets, including inventory growth, inflows of private and public funding and employment growth. 
>>Access Emerging Markets  External Link

Europe 
A spotlight on European life sciences markets and trends. The European life sciences sector is steadily maturing, as the hype of the pandemic passes and the tougher funding environment is absorbed. 
>>Access Europe  External Link